29938395Van Swearingen AED, Siegel MB, Deal AM, Sambade MJ, Hoyle A, Hayes DN, Jo H, Little P, Dees EC, Muss H, Jolly T, Zagar TM, Patel N, Miller CR, Parker JS, Smith JK, Fisher J, Shah N, Nabell L, Nanda R, Dillon P, Abramson V, Carey LA, Anders CKBreast cancer research and treatmentAntineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast NeoplasmsAdult; Aged; Biomarkers, Tumor; Disease Progression; DNA Copy Number Variations; Everolimus; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Molecular Targeted Therapy; Mutation; Neoplasm Metastasis; Receptor, ErbB-2; Survival Analysis; Trastuzumab; Treatment Outcome; VinorelbineLCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases. Breast Cancer Res Treat. 2018 Oct; 171(3):637-648.Breast Cancer Res Treat2018-06-25T00:00:002018LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD001943Disorders38828810.371998Breast NeoplasmsD000328Living Beings1578255770.254432AdultD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsAuthorship 109018200.1677320.1677321authors10.2520has subject areaD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD009154Physiology70239520.442648MutationD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD014408Chemicals & Drugs32614610.548098Biomarkers, TumorMedicine-Hematology and OncologyD016896Concepts & Ideas101179490.402389Treatment OutcomeD009362Disorders26910560.715963Neoplasm MetastasisD018450Physiology49815310.700842Disease ProgressionD058990Procedures1352660.831095Molecular Targeted TherapyD016019Concepts & Ideas43415360.742907Survival AnalysisD056915Physiology991710.899103DNA Copy Number VariationsD018719Chemicals & Drugs832230.868888Receptor, ErbB-2D001932Disorders2197630.646147Brain NeoplasmsD00006833828400.97566EverolimusD00006887836680.961481TrastuzumabD008279Concepts & IdeasProcedures53033470.417684Magnetic Resonance ImagingUniversity of ChicagoRitaNandaxWxoBaUUOfnamXNnYUHhvWD+6g==Rita Nanda41.78927490000000-87.601250000000001717Nanda, RitaAssociate Professortrue1Associate ProfessorAssociate Professor